PuSH - Publikationsserver des Helmholtz Zentrums München

Pressler, A.* ; Grosber, M. ; Halle, M.* ; Ring, J. ; Brockow, K.

Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema.

Clin. Exp. Dermatol. 38, 151-153 (2013)
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Vibratory angio-oedema is a rare form of physical urticaria characterized by pruriginous weals and angio-oedema at the site of exposure to vibration. Severe treatment-resistant disease can occur, and is associated with significant disability. Therapy with omalizumab, a monoclonal IgG anti-IgE antibody, has been shown to be successful in several types of physical urticaria. We report a patient with vibratory angio-oedema for whom all standard treatments for urticaria, including omalizumab, failed to show a clinical benefit. Finally, ketotifen was tried, and unexpectedly reduced symptoms significantly. Ketotifen may thus represent a therapeutic option in patients with treatment-resistant vibratory angio-oedema.
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Urticaria
ISSN (print) / ISBN 0307-6938
e-ISSN 1365-2230
Quellenangaben Band: 38, Heft: 2, Seiten: 151-153 Artikelnummer: , Supplement: ,
Verlag Wiley
Begutachtungsstatus Peer reviewed